SANUWAVE Health Hits 52-Week Low at $21.80 Amid Market Challenges

SANUWAVE Health, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low of USD 21.80 on March 6, 2026. This significant decline highlights the stock's volatility over the past year, particularly when compared to its 52-week high of USD 46.59. The company's market capitalization stands at approximately USD 208 million, indicating its position within the microcap category. SANUWAVE Health has not reported any earnings, as reflected by its loss-making status, which is further underscored by a negative return on equity of -999,999.00%. Additionally, the company has a debt-to-equity ratio of -4.76, suggesting a unique financial structure that may impact its operational flexibility. Over the past year, SANUWAVE Health's performance has been notably below that of the S&P 500, which has seen a gain of 17.45%. As the stock navigates these challenging market conditions, its recent performance metrics will be closely monitored by stakeholders in the industry.